Prudential Financial’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Prudential Financial’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,230	Closed	-$313K	–	2514
2019 Q3	$313K	Sell	3,230 -200	-6%	-$20K	﹤0.01%	2191
2019 Q2	$351K	Buy	3,430 +358	+12%	+$38.6K	﹤0.01%	2178
2019 Q1	$350K	Buy	+3,072	New	+$226K	﹤0.01%	2180
2018 Q3	–	Sell	-3,042	Closed	-$252K	–	2493
2018 Q2	$252K	Buy	+3,042	New	+$235K	﹤0.01%	2267
2017 Q4	–	Sell	-2,675	Closed	-$239K	–	2376
2017 Q3	$239K	Buy	+2,675	New	+$203K	﹤0.01%	2215

Prudential Financial's ONCE Position: Q4 2019 in Review

Prudential Financial sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 3,230 shares — an estimated $313K sold.

Prudential Financial first reported a position in ONCE in Q3 2017 and held it in 5 quarters. The position peaked at $351K in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Prudential Financial reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Prudential Financial sold 3,230 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $313K.
Prudential Financial first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
Prudential Financial's Spark Therapeutics, Inc. Common Stock position peaked at $351K in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Prudential Financial's 13F filing for Q4 2019, filed 11 Feb 2020.